Skip to content

Gain the advantage with ready-to-use screening assays

Robust and reliable iPSC-based assays for any drug modality

Explore Assays

As pioneers and innovators in iPSC technology we offer a wide range of cell-based assays amenable for high-throughput screening to study drugs' efficacy and safety for any therapeutic modality

The Benefits of Ncardia's Assays

Robust and Sensitive

Standardized assays based on human iPSC technology

Translational Results

Evaluate disease relevant
readouts

Quick Turnaround

Catalyze your decision-making steps

 

Our offering

Select a type
Alzheimer's Disease Ncyte® Neural Mix or hiPSC-microglia
Parkinson's Disease Ncyte® Neural Mix or hiPSC-dopaminergic neurons
ALS / FTD hiPSC-derived motor neurons
Neuroinflammation Co-culture of hiPSC-derived neurons with astrocytes or microglia
Cardiac Hypertrophy Ncyte® vCardiomyocytes
Gene Modulation Cell model of your choice
Neurotoxicity hiPSC-derived model of your choice
Cardiotoxicity hiPSC-derived cardiomyocytes
Endothelial Barrier Function Ncyte® Endothelial Cells
Atrial Fibrillation Coming Soon
3D Cardiac Microtissues Coming Soon
3D Mature Neurospheres Coming Soon
Peripheral Neuropathy - Pain assay Coming Soon

Alzheimer's Disease

Readout Technology
Phosphorylated TAU High Content Imaging
MC-1 soluble TAU aggregates
Insoluble TAU aggregates
Proteasomal Activity
Neurite growth
Cytokine release MSD, HTRF, ELISA
Electrophysiology MEA

Are you interested on this screening assay?

Request Screening Assay

Are you looking for a custom solution?

Contact Us

Not what you are looking for? Discover our custom iPSC solutions for drug discovery

Your Trusted Partner to Maximize Long-term Success

Set the Ground Rules

We sit together to understand your needs and set project goals 

Plan the Process

We set a project plan with clear timelines and milestones matching your needs

Execute and Report

Through frequent and transparent communication you can follow project execution 

Plan for the Future

We explain the final results and discuss how to support your next steps

 

Ready to start a conversation?

As more and more drug innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as the uniquely qualified partner to join them on their all-important journeys.

Shushant Jain, PhD Director of Discovery Technology
Shushant Jain, PhD